1. Home
  2. USLM vs BEAM Comparison

USLM vs BEAM Comparison

Compare USLM & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USLM

United States Lime & Minerals Inc.

N/A

Current Price

$121.87

Market Cap

3.0B

Sector

Industrials

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$28.46

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USLM
BEAM
Founded
1948
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
USLM
BEAM
Price
$121.87
$28.46
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$138.00
$50.75
AVG Volume (30 Days)
141.5K
1.7M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
0.19%
N/A
EPS Growth
23.22
82.31
EPS
2.26
N/A
Revenue
$144,435,000.00
$24,000.00
Revenue This Year
$27.25
N/A
Revenue Next Year
$13.76
$33.77
P/E Ratio
$52.85
N/A
Revenue Growth
N/A
33.33
52 Week Low
$96.27
$16.03
52 Week High
$141.44
$38.26

Technical Indicators

Market Signals
Indicator
USLM
BEAM
Relative Strength Index (RSI) 59.52 N/A
Support Level $115.16 N/A
Resistance Level $119.06 N/A
Average True Range (ATR) 2.94 0.00
MACD -0.12 0.00
Stochastic Oscillator 63.69 0.00

Price Performance

Historical Comparison
USLM
BEAM

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. The company supplies its products predominantly to the construction including highway, road, and building contractors, industrial including paper and glass manufacturers, environmental including municipal sanitation and water treatment facilities and flue gas treatment processes, metals including steel producers, oil and gas services, roof shingle manufacturers and agriculture including poultry industries. The company operates through its Lime and Limestone Operations segment.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: